World Orphan Drug Congress 2021

Our mission is to facilitate that patients with diseases for which no or only limited treatment options are available receive access to effective treatments. Therefore, Dr. Ingo Hantke and Fenja Lang will meet with a wide variety of stakeholders from the orphan drug industry at the World Orphan Drug Congress.

"I am very pleased that this year's agenda includes exciting presentations on gene and cell therapies in addition to orphan drugs. At SKC, we like to tackle new challenges and the World Orphan Drug Congress provides insights about what challenges different players are prioritizing and how they plan to address them. You also meet long-time and new clients, as well as inspiring peers who are working towards the same goal: That patients with rare diseases have access to effective treatment!" explains Fenja Lang, Head of Business Development, from SKC Consulting.

Are you also participating in this event? Please get in touch with us for a personal meeting.